Westminster, CA – November 3, 2022 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced it has added two new board members to its team: Linda Park and Christina Bray. Both new board members have a background, education, and corporate experience that make them an ideal fit to advance BioLargo’s core organizational goals, and its vision to “make life better” through its cleantech products and services.
Linda Park is a trusted executive and legal professional
with a proven track record of supporting and advising public companies. With corporate
board and executive experience at billion-dollar corporations such as her
current roles working with Edward Lifesciences in her capacity as Corporate
Secretary, Senior Vice President and Associate General Counsel, and Board
Member of the Edwards Lifesciences Foundation, and prior work with Western
Digital Corporation, Linda brings over 20 years of experience advancing organizations’
corporate governance and strategic goals. She also has many years of experience
advising issuer and investment banking clients on corporate and securities
matters, mergers and acquisitions, bank financings and capital markets,
including initial public offerings. She is also an active partner and thought
leader on environmental, social, and corporate governance issues. Linda has an
undergraduate degree from Johns Hopkins University, and a law degree from Duke
University School of Law.
Christina Bray is a senior finance specialist, entrepreneur,
and renewables specialist, and currently serves as the CEO and founder of Bluedot
Energies, an innovative company that designs, builds, and manages electric
vehicle charging stations for large-scale public and private applications. A
rising star in green energy technologies, Christina has significant finance,
capital projects, and corporate operation experience, having negotiated M&A
activities and managed $1 billion in quarterly loan volume at the solar fintech
company Sunlight Financial. She has extensive training including a master’s
degree in Military History from Norwich University and an undergraduate degree
in Middle Eastern Studies from Yale University. She is well-versed in middle
eastern language and society.
“We are so pleased that Linda Park and Christina Bray have
joined our Board of Directors,” said Dennis P. Calvert, BioLargo’s CEO. “Both
have such significant experience in advancing innovative projects, as well as
building and supporting successful companies. We know that they will make important
contributions to our efforts to transform BioLargo into a cleantech juggernaut.
With Linda and Christina on board, we couldn’t be more confident in the future
for our company.”
Concurrently, board members John S. Runyan and Kent C. (Rick)
Roberts II have retired from their positions on the Board of Directors where
they served faithfully for over a decade. Both will remain as formal Advisors
to the Board of Directors as their time permits.
Mr. Calvert commented, “John and Rick have made significant
contributions to the company over the years, and we are thankful for their
meaningful impact on the company. We look forward to working with them in the
future in their roles as Advisors to the board.”
About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) invents, develops, and
commercializes innovative technologies in the cleantech space, including for PFAS
contamination, advanced water and wastewater treatment, industrial odor and VOC
control, air quality control, and infection control. With over 13 years of
extensive R&D, BioLargo holds a wide array of issued patents, maintains a
robust pipeline of products, and provides full-service environmental
engineering. Our approach is to invent or acquire novel technologies and
develop them to maturity through our operating subsidiaries. We have developed
a number of key channel partnerships to support the reach of our products and
services and maximize their commercial potential. With a keen emphasis on
collaborations with academic, municipal, and commercial organizations and
associations, BioLargo has proven itself with over 90 awarded grants and
numerous pilot projects. We monetize through direct sales, recurring service
contracts, licensing agreements, strategic joint venture formation and/or the
sale of the IP. See our website at www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements include without limitation those about
BioLargo’s (the “Company”) expectations regarding anticipated revenue and plans
for future operations, and may be identified by words such as “we believe”.
These statements involve risks and uncertainties, and actual results may differ
materially from any future results expressed or implied by the forward-looking
statements. Risks and uncertainties include without limitation: the effect of
the COVID-19 pandemic on the Company’s business, results of operations,
financial condition, and stock price; the effect of global and regional
economic conditions on the Company’s business, including effects on purchasing
decisions by consumers and businesses; the ability of the Company to compete in
markets that are highly competitive and subject to rapid technological change;
the ability of the Company to manage frequent introductions and transitions of
products and services, including delivering to the marketplace, and stimulating
customer demand for, new products, services, and technological innovations on a
timely basis; the dependency of the Company on the performance of distributors
of the Company’s products. More information on these risks and other potential
factors that could affect the Company’s business and financial results is
included in the Company’s filings with the SEC, including in the “Risk Factors”
and “Management’s Discussion and Analysis of Financial Condition and Results of
Operations” sections of the Company’s most recently filed periodic reports on
Form 10-K and Form 10-Q and subsequent filings. The Company assumes no
obligation to update any forward-looking statements or information, which speak
as of their respective dates.
No comments:
Post a Comment